期刊文献+

原发性肝癌患者及其家族成员血清免疫抑制酸性蛋白的分析 被引量:2

Analysis of Serum Immunosuppressive Acidic Protein in Patients With Primary Hepatocellular Carcinoma and Their Familial Members
原文传递
导出
摘要 目的 评估血清免疫抑制酸性蛋白 (IAP)与原发性肝癌 (PHC)发生的相关性。方法 应用单向免疫琼脂扩散法检测3 0例PHC患者、3 0例家族成员 (FM)和 3 0例正常健康人 (NS)血清IAP水平。结果 PHC患者血清IAP水平 (85 1± 2 12 ) μg/ml与正常健康人 (2 78± 10 4) μg/ml比较有显著差异 (P <0 0 1) ;FM组 (5 73± 2 2 8) μg/ml与NS组比较有统计学差异 (P <0 0 1)。结论 IAP水平的改变可能与PHC发生相关 ,且IAP检测可被用于PHC易患个体的筛选。 Objective To evaluate the relationship between immunosuppresive acidic protein(IAP) and carcinogenesis of primary hepatocellular carcinoma (PHC).Methods Sera immunosuppresvie acidic protetin level were determined by using single immunodiffusion method in 30 patients with primary hepatocellular carcinoma(PHC),30 their familial members(FM) and 30 normal subjects(NS).Results Serum levels of IAP in patients with PHC(851±212)μg/ml, compared with NS(278±104)μg/ml, were significantly increased (P<0 01). There was also statistical difference in serum levels of IAP between FM(573±228)μg/ml and NS (P<0 01).Conclusions It is suggested that IAP may be associated with carcinogenesis of PHC. The changes of IAP may be served as an indicator of diagnosis for susceptible individuals of PHC.
作者 李明烈
出处 《中国医师杂志》 CAS 2003年第1期47-48,共2页 Journal of Chinese Physician
关键词 免疫抑制酸性蛋白 原发性肝癌 家族成员 PHC 单向免疫琼脂扩散法 Immunosuppressive acidic protein Primary hepatocellular carcinoma Family members
  • 相关文献

参考文献4

二级参考文献5

共引文献26

同被引文献51

  • 1王玉亮,张珩,李光,唐志琴,江雁,彭林.肝癌患者外周血淋巴细胞亚群、白细胞介素2和自然杀伤细胞活性的研究[J].中华检验医学杂志,2004,27(12):844-845. 被引量:8
  • 2于志伟,陈新新.血清α—L—岩藻糖苷酶测定对原发性肝癌的诊断意义[J].中华内科杂志,1989,28(7):394-396. 被引量:6
  • 3孟泽.新的血清唾液酸测定法用于肝癌与肝硬化鉴别诊断的价值[J].临床检验杂志,1996,14(2):75-77. 被引量:14
  • 4Yamazaki K, Yano T, Kameyama T, Suemitsu R, Yoshino I,Sugio K. Clinical significance of serum TH1/TH2 cytokines in patients with pulmonary adenocarcinoma. Surgery 2002;131(Suppl 1): S236-S241.
  • 5Tatsumi T, Kierstead LS, Ranieri E, Gesualdo L, Schena FP,Finke JH, Bukowski RM, Mueller-Berghaus J, Kirkwood JM,.Kwok WW, Storkus WJ. Disease-associated bias in T helper type 1 (Thl)/Th2 CD4(+) T cell responses, against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. J Exp Med 2002;196:619-628.
  • 6Sasada T, Kimura M, Yoshida Y, Kanai M, Takabayashi A.CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 2003;98:1089-1099.
  • 7Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V,Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002;169:2756-2761.
  • 8Junnikkala S, Hakulinen J, Jarva H, Manuelian T, Bjorge L,Butzow R, Zipfel PF, Meri S. Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumor cells. Br J Cancer 2002;87:1119-1127.
  • 9Durrant LG, Spendlove I. Immunization against tumor cell surface complement-regulatory proteins. Curr Opin Investig Drugs 2001;2:959-966.
  • 10Kuhn DJ, Smith DM, Pross S, Whiteside TL, Dou QP.Overexpression of interleukin-2 receptor alpha in a human squamous cell carcinoma of the head and neck cell line is associated with increased proliferation, drug resistance, and transforming ability. J Cell Biochern 2003;89:824-836.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部